🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Taiyuan
Clinical trial register · China

Clinical Trials in Taiyuan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Shanxi Bethune Hospital15 Cancer Institute and Hospital, Chinese Academy of Medical Sciences6 Second Hospital of Shanxi Medical University6 Alexion Pharmaceuticals, Inc.4 Shanxi Province Cancer Hospital4
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Taiyuan

144 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer
NCT07822646Ovarian Cancer
Chinese PLA General Hospital
Phase 3
120
Beijing, Tangshan, Taiyuan
2026-10-12
Not yet open
Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer
NCT07819669Multiple Primary Lung Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
160
Taiyuan, Beijing, Shenzhen
2026-09
Not yet open
Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B
NCT07809165Chronic Hepatitis B
Beijing 302 Hospital
Not applicable
60
Jinan, Taiyuan, Xi'an
2026-09
Not yet open
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Abbisko Therapeutics Co, Ltd
Phase 2
72
Guangzhou, Harbin, Wuhan, Shenyang, Shanghai, Taiyuan, Hangzhou
2026-08-31
Not yet open
VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors
NCT07772934Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
260
Zhejiang, Zhengzhou, Changsha, Nanchang, Shengyang, Shanghai, Taiyuan
2026-08-24
Not yet open
HMPL-A830 in Solid Tumors
NCT07718581Solid Tumor, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Chengdu, Guangzhou, Jinan, Nanjing, Taiyuan
2026-08-15
Not yet open
AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
NCT07712094Neuroendocrine Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
56
Baotou, Tongliao, Taiyuan, Tianjin
2026-08-01
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
NCT07733830Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
120
Beijing, Zhengzhou, Shenyang, Taiyuan, Chengdu, Tianjin
2026-07-31
Recruiting
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
NCT07596784Generalized Myasthenia Gravis, gMG
Alexion Pharmaceuticals, Inc.
Phase 3
20
Beijing, Changchun, Fuzhou, Jinan, Shanghai, Shijiazhuang, Taiyuan, Tianjin
2026-07-20
Recruiting
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07557420NMOSD, Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
NCT07640295Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Recruiting
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
NCT07689851Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Shenzhen, Taiyuan, Beijing
2026-07-01
Not yet open
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
NCT07596524Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing, Shenzhen, Taiyuan
2026-07-01
Recruiting
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
NCT07473726Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1
72
Guangzhou, Hongkou, Taiyuan
2026-06-30
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)
NCT07717905Chronic Spontaneous Urticaria
Bambusa Therapeutics
Phase 1/2
48
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jinzhou, Wuxi, Taiyuan, Xi’an
2026-06-29
Not yet open
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)
NCT07663838Randomized, Open-label, Safety, Tolerability
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Beijing, Nanjing, Nanchang, Changchun, Jinan, Taiyuan, Tianjin
2026-06-15
Not yet open
Transcutaneous Electrical Acupoint Stimulation for Perioperative Sleep Disturbances in Cancer Patients
NCT07654075Postoperative Sleep Disturbance
Second Hospital of Shanxi Medical University
Not applicable
176
Taiyuan
2026-06-13
Active, closed
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
NCT07791602Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Cancer, HNSCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
180
Beijing, Harbin, Shenyang, Taiyuan, Tianjin
2026-06-12
Recruiting
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
NCT07692165Ulcerative Colitis (UC)
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase 1/2
24
Guangzhou, Shenyang, Beijing, Hangzhou, Shanghai, Taiyuan, Weifang, Wenzhou
2026-06-11
Not yet open
Treatment of Recurrent/Metastatic Head and Neck Cancer
NCT07601204Recurrent/Metastatic Head and Neck Cancer
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1/2
128
Beijing, Guangzhou, Nanning, Wuhan, Changsha, Shenyang, Taiyuan, Chengdu
2026-06
Not yet open
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
NCT07582822Advanced Solid Tumor
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Recruiting
A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC
NCT07567521Prostate Cancer
C Ray Therapeutics
Phase 1/2
90
Taiyuan, Shanghai
2026-05-22
Not yet open
Ultrasound Assessment of Sciatic Nerve and Inferior Gluteal Artery in Diabetic Peripheral Neuropathy(DPN): Association With a Target Gene
NCT07595887Diabetic Peripheral Neuropathy (DPN)
Second Hospital of Shanxi Medical University
Observational
120
Taiyuan
2026-05-20
Not yet open
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
NCT07486648Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell), Advanced Non-small-cell Lung Cancer
Shanxi Province Cancer Hospital
Phase 1/2
53
Beijing, Taiyuan
2026-05-15
Recruiting
Impact of Allometric Pacing Rate on Ventricular Diastolic Function and Cerebral Blood Flow in Hypertensive Patients With Sinus Node Dysfunction
NCT07589452Bradycardia
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
70
Taiyuan
2026-05-14
Recruiting
QLS5212 for Participants With Advanced Solid Tumors
NCT07467629Solid Tumor Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 1
100
Taiyuan
2026-05-11
Recruiting
Dymista in Chinese Adolescents
NCT07597473Allergic Rhinitis Due to Allergens
Viatris Inc.
Phase 4
100
Beijing, Changsha, Chengdu, Dalian, Hangzhou, Nanchang, Shanghai, Taiyuan
2026-05-08
Recruiting
Minimum Effective Dose of Ropivacaine for Ultrasound-guided Interscalene Block
NCT07326943Hand and Forearm Trauma, Hand and Forearm Diseases
Huazhong University of Science and Technology
Not applicable
56
Taiyuan
2026-05-01
Recruiting
Impact of Via CT-based 3D Printing Technology on Success Rate in Endotracheal Intubation in Students
NCT07612995Endotracheal Intubation
xiaojing wang
Not applicable
80
Taiyuan
2026-05
Not yet open
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07583030Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD), Progressive Multiple Sclerosis (PMS), Relapsed/Refractory Myasthenia Gravis(r/r MS)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
44
Hefei, Beijing, Wuhan, Taiyuan
2026-04-20
Recruiting
A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
NCT07390383Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Shijiazhuang, Jinan, Qingdao, Taiyuan, Tianjin
2026-04-13
Recruiting
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
NCT07389460Acute Ischemic Stroke
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
820
Lanzhou, Shijiazhuang, Zhengzhou, Loudi, Dalian, Xining, Xi'an, Taiyuan
2026-04-07
Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
NCT07505810Epidemic Meningitis, Meningococcal Vaccines
Sinovac Biotech Co., Ltd
Phase 3
880
Nanning, Taiyuan
2026-03-25
Recruiting
DXP-106 in Solid Tumor Patients.
NCT07532018Solid Tumor, Cancer
Singlomics Biopharmaceuticals Zhuhai Co., Ltd.
Phase 1
54
Harbin, Shanghai, Taiyuan, Hangzhou
2026-03-23
Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
NCT07505836Epidemic Meningitis, Meningococcal Vaccines
Sinovac Biotech Co., Ltd
Phase 3
1,040
Nanning, Taiyuan
2026-03-22
Recruiting
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months
NCT07505823Epidemic Meningitis, Meningococcal Vaccines
Sinovac Biotech Co., Ltd
Phase 3
1,040
Nanning, Taiyuan
2026-03-22
Active, closed
An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
NCT07424144Chronic Rhinosinusitis With Nasal Polyps
Sanofi
Phase 3
59
Baotou, Beijing, Chengdu, Jingzhou, Shenyang, Taiyuan
2026-03-12
Recruiting
A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
NCT07486791ACS (Acute Coronary Syndrome), HF - Heart Failure
Xiling Qi
Not applicable
65
Taiyuan
2026-03-10
Recruiting
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
NCT07228312Intracranial Aneurysm
Johnson & Johnson Medical (Shanghai) Ltd.
Observational
200
Chenzhou, Guangzhou, Nanjing, Nanyang, Taiyuan, Wuhu, Zhengzhou
2026-01-28
Recruiting
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
NCT07514052Multiple Myeloma of Bone
Shanxi Bethune Hospital
Observational
127
Taiyuan
2026-01-01
Recruiting
A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors
NCT07321574SCLC, Extensive Stage, Advanced Solid Tumors
Shanghai AB PharmaTech Ltd.
Phase 2
110
Luoyang, Nanyang, Nanchang, Liaocheng, Shanghai, Taiyuan, Neijiang
2025-12-30
Recruiting
A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL
NCT07350850PCNSL, Primary Central Nervous System Lymphoma
Tongji Hospital
Phase 2
77
Xiamen, Wuhan, Changchun, Taiyuan
2025-12-25
Recruiting
GenSci143 in Participants With Advanced Solid Tumors
NCT07252414Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
180
Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Shanghai, Taiyuan, Hangzhou
2025-12-20
Recruiting
A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
NCT07323173Systemic Lupus Erythematosus
Nanjing Leads Biolabs Co.,Ltd
Phase 1
117
Bengbu, Beijing, Guangzhou, Changsha, Nanjing, Pingxiang, Shanghai, Taiyuan
2025-12-16
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H Cancer
Peking University
Phase 2
106
Shijiazhuang, Harbin, Zhengzhou, Nanjing, Xi'an, Qingdao, Taiyuan, Chengdu
2025-12-15
Recruiting
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
NCT07262645Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-15
Recruiting
A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging
NCT07333495Kidney Transplant, Renal Allograft Recipients, Renal Allograft
Tongji Hospital
Observational
1,000
Shiyan, Wuhan, Taiyuan
2025-12-04
Recruiting
A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease
NCT07640893Von Willebrand Disease (VWD)
Shanghai RAAS Blood Products Co., Ltd.
Phase 2
24
Changsha, Hefei, Jinan, Nanning, Suzhou, Taiyuan, Tangshan, Tianjin
2025-11-26
Recruiting
Intraosseous Infusion in Hematologic Critical Patients
NCT07239375Intraosseous Infusions
Shanxi Bethune Hospital
Observational
52
Taiyuan
2025-11-22
Recruiting
Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
NCT07239245Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
30
Beijing, Zhengzhou, Shenyang, Taiyuan
2025-11-12
Recruiting
Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL
NCT07175662High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 2
150
Beijing, Taiyuan
2025-11-11
Recruiting
Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management
NCT07265037Diabetes Mellitus, Type 2, Integrated Traditional Chinese Medicine and Western Medicine, Telemedicine, Chronic Disease Management
Shanxi Bethune Hospital
Not applicable
10,000
Taiyuan
2025-11-01
Recruiting
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
NCT07497165Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma
Shanxi Bethune Hospital
Observational
48
Taiyuan
2025-11-01
Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
NCT07190196Immunoglobulin G4 Related Disease
Sanofi
Phase 3
124
Beijing, Chengdu, Hangzhou, Jiazhuang, Taiyuan, Wuhan, Yantai
2025-09-26
Recruiting
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522Febrile Neutropenia
Shanxi Bethune Hospital
Observational
20
Taiyuan
2025-09-22
Recruiting
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
NCT07215650Generalized Myasthenia Gravis
Candid Therapeutics
Phase 1
44
Fuzhou, Guangzhou, Guiyang, Zhengzhou, Changchun, Shanghai, Taiyuan, Chengdu
2025-09-16
Recruiting
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382Plaque Psoriasis
Chipscreen Biosciences, Ltd.
Phase 1/2
220
Beijing, Chengde, Shijiazhuang, Shiyan, Jinan, Taiyuan, Xi’an, Hangzhou
2025-09-08
Recruiting
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
NCT06850285Lymphoma, B-Cell
Shanxi Bethune Hospital
Not applicable
15
Taiyuan
2025-09-05
Recruiting
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06841679Gastric or Gastroesophageal Junction Adenocarcinoma
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase 2/3
778
Anyang, Guangzhou, Jinan, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
2025-08-28
Not yet open
To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading
NCT06732362Diabetes Mellitus, Type 2
Zheng Guo
Observational
60
Taiyuan
2025-08-20
Recruiting
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
NCT07059650Diffuse Large B-Cell Lymphoma
Dizal Pharmaceuticals
Phase 1/2
150
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Linyi, Taiyuan
2025-08-19
Recruiting
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NCT07116096Liver Cirrhosis, Portal Hypertension
Shanxi Provincial People's Hospital
Not applicable
120
Luoyang, Taiyuan
2025-08-17
Recruiting
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
NCT07108530Acute Myeloid Leukemia
Shanxi Bethune Hospital
Phase 2
50
Taiyuan
2025-08-06
Recruiting
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
NCT06615596Atrial Fibrillation (AF)
China National Center for Cardiovascular Diseases
Phase EARLY_PHASE1
3,160
Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Shanghai, Taiyuan, Chengdu
2025-08-05
Recruiting
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035Cirrhosis, Decompensation, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Survival Analysis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
250
Changsha, Fuzhou, Huanggang, Jingzhou, Nanchang, Nanjing, Shenyang, Taiyuan
2025-08-01
Recruiting
A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors
NCT06990698Advanced Solid Tumors
Zhuhai Fapon Biopharma Co., Ltd.
Phase 1
108
Wuhan, Taiyuan, Hangzhou
2025-06-12
Not yet open
Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia
NCT07012902Induction Anesthesia, Drug Interactions
Second Hospital of Shanxi Medical University
Phase EARLY_PHASE1
125
Taiyuan
2025-06-12
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
NCT06962839Macular Edema
Boehringer Ingelheim
Phase 2
300
Chengdu, Shanghai, Shenyang, Shijiazhuang, Taiyuan
2025-06-05
Recruiting
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
NCT07059156Acute Lymphoblastic Leukemia, Adult
Shanxi Bethune Hospital
Phase 2/3
50
Taiyuan
2025-06-01
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
NCT06979869Esophageal Cancer
Xijing Hospital
Observational
300
Wuwei, Shantou, Zhaoqing, Zhengzhou, Xi'an, Yan’an, Taiyuan, Chengdu
2025-05-26
Not yet open
Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section
NCT06991985Amniotic Fluid Embolism
Second Hospital of Shanxi Medical University
Observational
120
Taiyuan
2025-05-20
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
NCT06830798Delayed Graft Function, DGF, Kidney Transplant
Alexion Pharmaceuticals, Inc.
Phase 3
450
Guangzhou, Hangzhou, Hengyang, Nanning, Shenzhen, Taiyuan, Tianjin, Zhengzhou
2025-05-19
Recruiting
A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer
NCT06623136Non-Small Cell Lung Cancer
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 2
40
Beijing, Zhengzhou, Nanchang, Changchun, Jinan, Luoyang, Taiyuan, Taizhou
2025-04-30
Recruiting
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
NCT06963281Solid Tumors
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 1
285
Guangzhou, Jinan, Taiyuan
2025-04-29
Recruiting
Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT
NCT06909071T2DM Patients With Traumatic Brain Injury
Shanxi Bethune Hospital
Not applicable
40
Taiyuan
2025-04-15
Recruiting
A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
NCT07010939Breast Neoplasms, Quality of Life (QOL), Toxicities, Breast Diseases
FangYi
Observational
3,000
Beijing, Shenzhen, Taiyuan
2025-04-07
Active, closed
A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma
NCT07713290Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer
Beijing Gene Key Life Technology Co., Ltd
Phase 1
6
Beijing, Taiyuan
2025-04-03
Recruiting
Child-Parent Familial Hypercholesterolemia Screening
NCT04529967Familial Hypercholesterolemia
Children's Hospital of Fudan University
Observational
15,000
Hefei, Qidong, Shanghai, Taiyuan, Chongqing, Ürümqi
2025-04-01
Recruiting
Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial
NCT06962410Diabetes Mellitus Patients With Kidney Transplantation
Shanxi Bethune Hospital
Not applicable
30
Taiyuan
2025-04-01
Recruiting
Hybrid Closed-Loop System in LADA Patients: A Randomized Trial
NCT06941675Latent Autoimmune Diabetes in Adults (LADA)
Shanxi Bethune Hospital
Not applicable
50
Taiyuan
2025-04-01
Recruiting
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
NCT06895928Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
400
Taiyuan
2025-03-28
Recruiting
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
NCT06803680Advanced Solid Tumor, Metastatic Solid Tumor
BeOne Medicines
Phase 1
90
Beijing, Nanchang, Shanghai, Taiyuan
2025-03-18
Recruiting
A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
NCT06796699Advanced Solid Tumors With MTAP Gene Deletion
Suzhou Genhouse Bio Co., Ltd.
Phase 1
90
Beijing, Shanghai, Taiyuan
2025-03-07
Active, closed
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
NCT06745323Small Cell Lung Cancer (SCLC)
Amgen
Phase 2
252
Beijing, Fuzhou, Guangzhou, Harbin, Changsha, Taiyuan, Chengdu, Tianjin
2025-02-26
Active, closed
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293Menstrual Migraine (MM)
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Not yet open
Sufentanil in Patients With Lower Extremity Fracture Surgery Myocardial Damage Function Study
NCT06808841Myocardial Injury
Second Hospital of Shanxi Medical University
Not applicable
160
Taiyuan
2025-02-05
Recruiting
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025Asthma
Beijing Chao Yang Hospital
Not applicable
200
Beijing, Guangzhou, Zhengzhou, Changsha, Shenyang, Shanghai, Taiyuan, Hangzhou
2025-02-01
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
Efficacy and Safety of DTMS in Adolescent Major Depressive Disorder
NCT06728280Major Depressive Diorder
Zhifen Liu
Not applicable
100
Taiyuan
2024-12-31
Recruiting
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
NCT07031544Obsessive - Compulsive Disorder
Shanghai Mental Health Center
Not applicable
60
Guangzhou, Shijiazhuang, Xinxiang, Nanchang, Taiyuan, Mianyang, Shanghai, Tianjin
2024-12-14
Recruiting
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
NCT06596694Gastrointestinal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
180
Hefei, Fuzhou, Xiamen, Guangzhou, Nanning, Zhengzhou, Shanghai, Taiyuan
2024-11-03
Recruiting
Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients
NCT06678529Delirium - Postoperative, Hip Fractures (ICD-10 72.01-72.2)
Huazhong University of Science and Technology
Not applicable
160
Taiyuan
2024-11-01
Recruiting
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
NCT05188859Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
29
Taiyuan, Beijing
2024-09-01
Recruiting
Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
NCT06637007Sarcoma,Soft Tissue, Sarcoma, Sarcoma of Bone
Shanxi Province Cancer Hospital
Phase 2
30
Taiyuan
2024-08-01
Recruiting
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
NCT06536868Extensive-stage Small-cell Lung Cancer
Second Hospital of Shanxi Medical University
Phase 2
40
Jincheng, Jinzhong, Taiyuan
2024-08-01
Active, closed
SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI
NCT07010965High-Risk PCI
magAssist, Inc.
Not applicable
236
Beijing, Changsha, Guangzhou, Hangzhou, Harbin, Lanzhou, Shanghai, Taiyuan
2024-07-31
Recruiting
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
NCT06400537Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
25
Wuhan, Taiyuan
2024-07-20
Active, closed
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
NCT06465914Genital Wart, Penile Cancer, Anal Cancer, PIN-1
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3
9,000
Nanning, Changsha, Taiyuan, Chengdu, Kunming
2024-07-11
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
NCT06024746Heart Failure
Colorado Prevention Center
Phase 3
1,500
Guangzhou, Changsha, Jinan, Shanghai, Taiyuan, Xian City, Chengdu, Tianjin
2024-07-09
Recruiting
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease
NCT06818838Gaucher Disease Type 1
Lingyi Biotech Co., Ltd.
Phase 1/2
12
Guangzhou, Taiyuan, Tianjin
2024-07-05
Rows per page Showing 1–100 of 144
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/taiyuan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 144 of those studies with a site in Taiyuan.

How many clinical trials are recruiting in Taiyuan?

93 of the 144 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 22 have not yet opened recruitment, 28 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Taiyuan), 144 studies
PhaseStudiesRecruitingShare
Phase 2302020.8%
Not applicable271918.8%
Phase 3271318.8%
Observational201213.9%
Phase 1161311.1%
Phase 1/214109.7%
Phase EARLY_PHASE1523.5%
Phase 2/3322.1%
Phase 4221.4%

Most active sponsors

Lead sponsors with the most studies (Taiyuan)
Lead sponsorStudiesRecruiting
Shanxi Bethune Hospital1514
Cancer Institute and Hospital, Chinese Academy of Medical Sciences63
Second Hospital of Shanxi Medical University61
Alexion Pharmaceuticals, Inc.43
Shanxi Province Cancer Hospital42
Changchun GeneScience Pharmaceutical Co., Ltd.31
Novartis Pharmaceuticals30
Sanofi31
Sinovac Biotech Co., Ltd33
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.